Department of Gynecology, Wuhan Children's Hospital Affiliated by Tongji Medical College of Huazhong University of Science and Technology, Jiangan, Wuhan, Hubei, China
Auto-generated profile, based on publicly available information
Zhihui Liu
Department of Gynecology, Wuhan Children's Hospital Affiliated by Tongji Medical College of Huazhong University of Science and Technology, Jiangan, Wuhan, Hubei, China
The aim of the present study was to meta-analyze the literature on the diagnostic value of 18-fluorodeoxyglucose (18F-FDG) positron emission tomography (PET) with or without computed tomography (CT) in detecting extrahepatic metastases or local residual/recurrent hepatocellular carcinoma (HCC). Systematic review of literature in MEDLINE, Embase, and Cochrane databases was conducted in March 2017, and relevant studies analyzing the diagnostic performance of 18F-FDG PET with or without CT were meta-analyzed. Meta-analysis was carried out on data from 11 studies involving 572 patients. 18F-FDG PET, with or without CT, showed pooled sensitivity of 64% and pooled specificity of 95%. Pooled sensitivity was similar with CT (74%) or without (52%; P = .279). Similarly, pooled specificity was comparable with CT (93%) or without 95% (P = .481). 18F-FDG PET, with or without CT, shows relatively low sensitivity but high specificity for diagnosing extrahepatic metastases or local residual/recurrent HCC. Adding CT to 18F-FDG PET may improve diagnostic performance, but the available evidence suggests that the improvement is not statistically significant.
23 December 2018 in Journal of Cellular Biochemistry